Vyriad, Inc.
Biotechnology company · Rochester, Minnesota, United States
Vyriad, Inc. is a biotechnology company headquartered in Rochester, Minnesota, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $4.1 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2019.
Vyriad at a glance
What does Vyriad do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $4.1 million in total (2017 to 2019). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $24.4 million sold (2019).
Frequently asked questions about Vyriad
Where is Vyriad headquartered?
Vyriad, Inc. is headquartered in Rochester, Minnesota, United States.
What does Vyriad do?
Vyriad, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.